Strategic alliances and collaborations are an important component of Quanterix’s overall business strategy. Quanterix is actively working with academic and commercial partners to develop and validate bioassays that address unmet needs in clinical diagnostics. Quanterix will also explore partnerships to develop instrumentation and reagents for the life science research and IVD markets.

We encourage you to contact us if your current immunoassay analysis of biomarkers, proteins or small molecules is hindered by insufficient limits of detection and quantification.